TY - JOUR
T1 - Computational Modeling of Neurotransmitter Release Evoked by Electrical Stimulation
T2 - Nonlinear Approaches to Predicting Stimulation-Evoked Dopamine Release
AU - Trevathan, James K.
AU - Yousefi, Ali
AU - Park, Hyung Ook
AU - Bartoletta, John J.
AU - Ludwig, Kip A.
AU - Lee, Kendall H.
AU - Lujan, J. Luis
N1 - Funding Information:
This work was supported by the National Institutes of Health, NINDS (R01 NS084975 award to J.L.L. and R01 NS75013 and R01 NS70872 awards to K.H.L.), and The Grainger Foundation.
Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/2/15
Y1 - 2017/2/15
N2 - Neurochemical changes evoked by electrical stimulation of the nervous system have been linked to both therapeutic and undesired effects of neuromodulation therapies used to treat obsessive-compulsive disorder, depression, epilepsy, Parkinson’s disease, stroke, hypertension, tinnitus, and many other indications. In fact, interest in better understanding the role of neurochemical signaling in neuromodulation therapies has been a focus of recent government- and industry-sponsored programs whose ultimate goal is to usher in an era of personalized medicine by creating neuromodulation therapies that respond to real-time changes in patient status. A key element to achieving these precision therapeutic interventions is the development of mathematical modeling approaches capable of describing the nonlinear transfer function between neuromodulation parameters and evoked neurochemical changes. Here, we propose two computational modeling frameworks, based on artificial neural networks (ANNs) and Volterra kernels, that can characterize the input/output transfer functions of stimulation-evoked neurochemical release. We evaluate the ability of these modeling frameworks to characterize subject-specific neurochemical kinetics by accurately describing stimulation-evoked dopamine release across rodent (R2 = 0.83 Volterra kernel, R2 = 0.86 ANN), swine (R2 = 0.90 Volterra kernel, R2 = 0.93 ANN), and non-human primate (R2 = 0.98 Volterra kernel, R2 = 0.96 ANN) models of brain stimulation. Ultimately, these models will not only improve understanding of neurochemical signaling in healthy and diseased brains but also facilitate the development of neuromodulation strategies capable of controlling neurochemical release via closed-loop strategies.
AB - Neurochemical changes evoked by electrical stimulation of the nervous system have been linked to both therapeutic and undesired effects of neuromodulation therapies used to treat obsessive-compulsive disorder, depression, epilepsy, Parkinson’s disease, stroke, hypertension, tinnitus, and many other indications. In fact, interest in better understanding the role of neurochemical signaling in neuromodulation therapies has been a focus of recent government- and industry-sponsored programs whose ultimate goal is to usher in an era of personalized medicine by creating neuromodulation therapies that respond to real-time changes in patient status. A key element to achieving these precision therapeutic interventions is the development of mathematical modeling approaches capable of describing the nonlinear transfer function between neuromodulation parameters and evoked neurochemical changes. Here, we propose two computational modeling frameworks, based on artificial neural networks (ANNs) and Volterra kernels, that can characterize the input/output transfer functions of stimulation-evoked neurochemical release. We evaluate the ability of these modeling frameworks to characterize subject-specific neurochemical kinetics by accurately describing stimulation-evoked dopamine release across rodent (R2 = 0.83 Volterra kernel, R2 = 0.86 ANN), swine (R2 = 0.90 Volterra kernel, R2 = 0.93 ANN), and non-human primate (R2 = 0.98 Volterra kernel, R2 = 0.96 ANN) models of brain stimulation. Ultimately, these models will not only improve understanding of neurochemical signaling in healthy and diseased brains but also facilitate the development of neuromodulation strategies capable of controlling neurochemical release via closed-loop strategies.
KW - Fast scan cyclic voltammetry
KW - Volterra kernels
KW - artificial neural network
KW - deep brain stimulation
KW - dopamine
KW - machine learning
KW - neurochemical sensing
UR - http://www.scopus.com/inward/record.url?scp=85013750825&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013750825&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.6b00319
DO - 10.1021/acschemneuro.6b00319
M3 - Article
C2 - 28076681
AN - SCOPUS:85013750825
SN - 1948-7193
VL - 8
SP - 394
EP - 410
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 2
ER -